What does the ATRIA bleeding score measure?

It estimates the annual probability of a major bleeding event (requiring transfusion, causing significant disability, or fatal) in patients with atrial fibrillation taking warfarin anticoagulation therapy.

How is anemia defined in the ATRIA score?

Anemia is defined as hemoglobin < 13 g/dL in men or < 12 g/dL in women, or a hematocrit < 40% in men or < 36% in women at the time of scoring.

How is renal disease defined in the ATRIA score?

Severe renal disease is defined as an estimated GFR < 30 mL/min/1.73 m² or dialysis dependence in the original ATRIA bleeding model.

What bleeding rates correspond to each risk category?

Low risk (score 0-3): approximately 0.8% annual bleeding rate. Intermediate (score 4): approximately 2.6%. High risk (score 5-10): approximately 5.8% annual major bleeding rate.

Should I use ATRIA score alone to decide on anticoagulation?

No. The ATRIA score is a decision-support tool only. Bleeding risk must always be weighed against stroke risk using validated tools such as CHA2DS2-VASc. Clinical judgment and patient preferences are essential.

Does this calculator apply to direct oral anticoagulants (DOACs)?

The ATRIA score was validated specifically for warfarin. Its applicability to DOACs has not been formally validated, though clinicians sometimes use it as a general bleeding risk reference.

ATRIA Bleeding Score

Calculate the ATRIA bleeding risk score to estimate major bleeding risk in atrial fibrillation patients on warfarin.

Patient Risk Factors

Select all that apply to the patient.

Anemia Hgb <13 g/dL (men) or <12 g/dL (women) +3 pts

Severe Renal Disease eGFR <30 mL/min/1.73 m² or dialysis +3 pts

Age ≥ 75 years Patient is 75 years old or older +2 pts

Prior Bleeding History of any hemorrhagic event requiring attention +1 pt

Hypertension Diagnosed hypertension or on antihypertensive therapy +1 pt

Select risk factors and click Calculate Score

Summary

The ATRIA bleeding score estimates the annual risk of major bleeding events in patients with atrial fibrillation who are taking warfarin. It was derived from a large cohort study and assigns points based on five clinical risk factors. The total score categorizes patients as low, intermediate, or high risk to guide anticoagulation decisions.

How it works

Enter patient clinical data including age, anemia status, and history of bleeding, renal disease, and hypertension.
Each risk factor is assigned a weighted point value based on the original ATRIA study derivation.
Points are summed to produce a total score between 0 and 10.
The score maps to one of three risk categories: low (0-3), intermediate (4), or high (5-10).
Estimated annual major bleeding rates are displayed alongside the category for clinical context.

Use cases

Assess bleeding risk before initiating warfarin in atrial fibrillation patients.
Re-evaluate anticoagulation safety during routine cardiology follow-up.
Compare bleeding risk against stroke risk (e.g., CHA2DS2-VASc) to guide therapy decisions.
Support shared decision-making conversations with patients about anticoagulation.
Identify modifiable risk factors such as uncontrolled hypertension or anemia.
Document risk stratification in clinical notes or pre-procedure assessments.

Frequently Asked Questions

Last updated: 2026-09-30 · Reviewed by Nham Vu